FDA
-
-
-
-
-
-
-
Artivion reports first quarter revenue growth, exercises Endospan option
-
-
-
-
-
-
-
Artivion (AORT) Reiterated at Buy by Stifel After Physician Conversations
-
-
-
-
-
-
-
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Artivion Inc. (AORT)
-
-
-
-
-
-
-
Artivion (AORT) Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
-
-
-
-
-
-
-
Artivion (AORT) Amends Agreements with Endospan
-
-
-
-
-
-
-
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
-
323,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

